CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 20, 2006--Sirtris Pharmaceuticals, the leading sirtuin therapeutics company, today announced that it will be presenting at the 5th International Metabolic Diseases Drug Discovery World Summit in San Diego, CA. Peter Elliott, Ph.D., Senior Vice President and Head of Development at Sirtris, will present "SIRT1 Activation: a novel mechanism for treating diabetes" and discuss the Company's strategy for discovering and developing first-in-class therapeutics that modulate sirtuins, the body's own health-promoting proteins. His presentation will be delivered at 4:45pm PST on Monday, July 24th, 2006.
